JBHT: Strong Q2 Confirms Recovery, But Valuation Limits Upside

What happened

J.B. Hunt delivered a strong Q2 2026, with intermodal EBIT surging 58% on 10% volume growth, confirming the operating leverage and network efficiency gains highlighted in prior filings. The dedicated segment remains stable with 96% retention, while ICS and TL show early recovery signs but face margin pressure. However, the stock has already rallied significantly, and the valuation now reflects the improved outlook, leaving little room for error. The key question shifts from 'if' the recovery happens to 'how much' pricing can further improve in the second half.

Implication

Investors should recognize that the intermodal recovery is materializing, with EBIT growth outpacing revenue gains—a sign of successful cost execution and network balance. However, at 35x+ P/E, the stock already embeds this recovery. The next catalyst is the pricing reset in the second half of 2026. If intermodal revenue per load turns positive, the stock could grind higher; if not, multiple compression is likely. Long-term investors should wait for a pullback closer to $200 or for clear evidence of sustained pricing power before adding. For those already holding, maintain position but set trim levels at $245 per the master report.

Thesis delta

The thesis shifts from 'waiting for recovery' to 'recovery confirmed but fully priced.' The WAIT rating is maintained as the risk/reward is now balanced. The bull case hinges on further pricing improvements in 2H26; the bear case is that current valuation already discounts that improvement, leaving no margin of safety.